Advanced search
Start date
Betweenand


Autophagy and intermittent fasting: the connection for cancer therapy?

Full text
Author(s):
Antunes, Fernanda ; Erustes, Adolfo Garcia ; Costa, Angelica Jardim ; Nascimento, Ana Carolina ; Bincoletto, Claudia ; Ureshino, Rodrigo Portes ; Silva Pereira, Gustavo Jose ; Smaili, Soraya Soubhi
Total Authors: 8
Document type: Journal article
Source: Clinics; v. 73, p. 7-pg., 2018-01-01.
Abstract

Cancer is a leading cause of death worldwide, and its incidence is continually increasing. Although anticancer therapy has improved significantly, it still has limited efficacy for tumor eradication and is highly toxic to healthy cells. Thus, novel therapeutic strategies to improve chemotherapy, radiotherapy and targeted therapy are an important goal in cancer research. Macroautophagy (herein referred to as autophagy) is a conserved lysosomal degradation pathway for the intracellular recycling of macromolecules and clearance of damaged organelles and misfolded proteins to ensure cellular homeostasis. Dysfunctional autophagy contributes to many diseases, including cancer. Autophagy can suppress or promote tumors depending on the developmental stage and tumor type, and modulating autophagy for cancer treatment is an interesting therapeutic approach currently under intense investigation. Nutritional restriction is a promising protocol to modulate autophagy and enhance the efficacy of anticancer therapies while protecting normal cells. Here, the description and role of autophagy in tumorigenesis will be summarized. Moreover, the possibility of using fasting as an adjuvant therapy for cancer treatment, as well as the molecular mechanisms underlying this approach, will be presented. (AU)

FAPESP's process: 08/11515-3 - Mechanisms of Intracellular Calcium Signaling int the Modulation of Apoptosis and Autophagy
Grantee:Soraya Soubhi Smaili
Support Opportunities: Regular Research Grants
FAPESP's process: 13/20073-2 - Autophagy as a protective mechanism in senescent rats
Grantee:Soraya Soubhi Smaili
Support Opportunities: Regular Research Grants